In breast cancer, RNF181 prolongs the stability of ERa associated with AF1 via its RING domain binding to the domain of ERa, and enhancement of the gene expression of ERa promotes breast cancer progression (Zhu et al., 2020). The gene discussed is RNF181; the disease is breast carcinoma.